Cell Isolation Market to Reach Valuation of USD 15.10 Billion by 2028 – Increasing Base Population of Patients Suffering from Cancer and Infectious Diseases is to Flourish the Market

In terms of revenue, the Global Cell Isolation Market is expected to reach USD 15.10 Billion by 2028, growing at a Compound Annual Growth Rate (CAGR) of 18.1% from 2022 to 2028. An increasing number of patients suffering from cancer and infectious diseases along with a growing focus on personalized medicine and technological advancements are the driving factors for the Cell Isolation Market. Furthermore, increasing funding from the government as well as major players for R&D is fueling the market growth.

Key Findings:

• Under the cell type segment, the human cells sub-segment is anticipated to dominate the segment for Cell Isolation Market and grow at a substantial Compound Annual Growth Rate (CAGR). The growth is attributed to the rising incidence of diseases such as cancer and cardiac abnormalities as well as advancement in cell isolation techniques.
• Consumables sub-segment held a market significant share in 2021 for product segment for Cell Isolation Market. The growth is attributed to extensive use in biomolecule isolation.
• North America is the largest regional segment. This is due to its increasing government support for cancer and stem cell research in the region.

Some of key players in Global Cell Isolation Market include – Becton Dickinson and Company (US), GE Healthcare (US), Merck KgaA (Germany), Thermo Fisher Scientific (US), Bio-Rad Laboratories Inc (US) are the major companies operating in Cell Isolation Market..

The escalating prevalence of infectious diseases has led to advancements in Research and development (R&D) through cell isolation techniques, which is expected to boost the overall Cell Isolation Market. Currently, the patient is getting aware of early diagnosis, which is also called a preventive diagnosis. This type of diagnosis is done to monitor normal body working at a particular interval of time, which helps in avoiding severe and life-threatening disease conditions. The overall rise in the patient pool with high awareness regarding disease diagnosis is expected to further drive the Cell Isolation Market. According to World Health Organization (WHO), the leading cause of death worldwide is cancer. According to the American Cancer Society, there are an estimated 16.9 million cancer patients/survivors in 2020. Thus, the swelling number of patients suffering from cancer and infectious diseases is increasing the demand for cell isolation. Consequently, driving cell isolation market growth over the forecast period.

North America is expected to emerge as potential market for Cell Isolation Market. The market growth in the region is attributed to factors such as well-established pharmaceutical and biotech industries, and high prevalence of chronic and infectious diseases. Additionally, extensive research activities by research universities in the field of cell therapies is further propelling the Cell Isolation market growth over the forecast period.